The risk-benefit task of research ethics committees: An evaluation of current approaches and the need to incorporate decision studies methods

Autor: Bernabe Rosemarie D L C, van Thiel Ghislaine J M W, Raaijmakers Jan A M, van Delden Johannes J M

Publikováno v: BMC Medical Ethics, Vol 13, Iss 1, p 6 (2012)

Abstract Background Research ethics committees (RECs) are tasked to assess the risks and the benefits of a trial. Currently, two procedure-level approaches are predominant, the Net Risk Test and the Component Analysis. Discussion By looking at decisi

Externí odkaz: https://doaj.org/article/0152a33a6e5c459d808c57b26d09aea9

Asthma treatment patterns in Dutch children using medication dispensing data

Autor: Arabkhazaeli, Ali, Vijverberg, Susanne J H, Van Der Ent, C. Kors, Raaijmakers, Jan A M, Maitland-van der Zee, Anke H, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: Pediatric Allergy and Immunology, 28(6), 606. Blackwell Munksgaard

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::ba04eccba3279c9ef7bd06448e7d1be3
https://dspace.library.uu.nl/handle/1874/361871

Characteristics and severity of asthma in children with and without atopic conditions: A cross-sectional study

Autor: Arabkhazaeli, Ali, Vijverberg, Susanne J. H., van Erp, Francine C., Raaijmakers, Jan A. M., van der Ent, Cornelis K., Maitland van der Zee, Anke H., Sub Gen. Pharmacoepi and Clinical Pharm, Sub Pharmacotherapy, Theoretical, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: BMC Pediatrics [E], 15(172). BioMed Central
BMC Pediatrics
BMC Pediatrics [E], 15(1), 172. BioMed Central

BACKGROUND: Childhood allergic diseases have a major impact on a child's quality of life, as well as that of their parents. We studied the coexistence of reported allergies in children who use asthma medication. Additionally, we tested the hypothesis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdea55983a196981dce4a4b8f897ec04
https://dspace.library.uu.nl/handle/1874/327270

Restoring trust in the pharmaceutical sector on the basis of the SSRI case

Autor: Hernandez, Juan Francisco, van Thiel, Ghislaine J. M. W., Mantel-Teeuwisse, Aukje K., Raaijmakers, Jan A. M., Pieters, Toine, Sub History and Philosophy of Science, Sub Pharmacoepidemiology, Sub Gen. Pharmacoepi and Clinical Pharm, Sub Pharmacotherapy, Theoretical, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: Hernandez, J F, van Thiel, G J M W, Mantel-Teeuwisse, A K, Raaijmakers, J A M & Pieters, T 2014, ' Restoring trust in the pharmaceutical sector on the basis of the SSRI case ', Drug Discovery Today, vol. 19, no. 5, pp. 523-527 . https://doi.org/10.1016/j.drudis.2013.11.019
Drug Discovery Today, 19(5), 523. Elsevier Ltd
Drug Discovery Today, 19(5), 523-527. Elsevier Limited

The lack of public trust in the pharmaceutical sector (i.e. industry, authorities and doctors) could compromise the future of drug development and the regulatory system. Public trust integrates two important components, namely the vulnerability of th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3320a45d00aeb326c3bcb0bd1c10c09d
https://research.vumc.nl/en/publications/00beac73-ff63-46df-b750-9824cfc7f882

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.